Understanding how RAG endonuclease controls immune cell development

Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination

NIH-funded research Children's Hosp of Philadelphia · NIH-10870099

This study is looking at how a specific enzyme helps control the process that makes our immune cells, like B and T cells, work properly, which is important for keeping our immune responses on target and preventing them from attacking our own bodies.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionChildren's Hosp of Philadelphia NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-10870099 on NIH RePORTER

What this research studies

This research investigates the mechanisms by which RAG endonuclease mediates feedback inhibition of V(D)J recombination, a crucial process in the development of B and T cells. By studying the role of the ATM kinase in this process, the research aims to uncover how the body ensures that immune responses are specific and prevents autoimmunity. The methodology involves examining genetic and molecular interactions in pre-B cells to understand how RAG-induced DNA breaks signal for the regulation of gene expression. This could lead to insights into immune system functioning and potential therapies for related disorders.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with conditions related to immune system dysfunction, such as autoimmune diseases or genetic immunodeficiencies.

Not a fit: Patients with unrelated health conditions or those not affected by immune system disorders may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment of autoimmune diseases and immune deficiencies.

How similar studies have performed: Previous research has shown promising results in understanding the role of ATM in immune cell regulation, indicating that this approach has potential for significant findings.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.